Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Pain 3Neoplasms 3Gastrointestinal Neoplasms 2Depression 2Anxiety Disorders 2Peripheral Nervous System Diseases 1Pain, Postoperative 1Otolaryngeal Cancer 1Neurotoxicity Syndromes 1Mucositis 1Lung Neoplasms 1Head and Neck Neoplasms 1Cancer Pain 1Breast Neoplasms 1Agnosia 1Acute Pain 1

Interventions

Cisplatin 75Cetuximab 63Radiotherapy 38pembrolizumab 29Radiotherapy, Intensity-Modulated 28Carboplatin 25Fluorouracil 24Docetaxel 24Paclitaxel 19Erlotinib Hydrochloride 13Nivolumab 12Radiation 10Pemetrexed 10durvalumab 8Gemcitabine 8Drug Therapy 8Bevacizumab 7zalutumumab 6Surgical Procedures, Operative 6Panitumumab 6Lapatinib 6Everolimus 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6epacadostat 5Standard of Care 5Oxaliplatin 5Gefitinib 5Afatinib 5Radiosurgery 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Head and Neck Neoplasms × Ketamine × Clear all
NCT01653327 2018-09-28

Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer

Dartmouth-Hitchcock Medical Center

Phase 2 Completed
11 enrolled 5 charts
Head & NeckOther

Head and Neck Neoplasms, Neoplasms, Pain, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡